Alessandro M. Vannucchi

Author

Also Known As

A M Vannucchi, A Maria Vannucchi, A VANNUCCHI, A Vannucchi, A. M. Vannucchi, A. M.Vannucchi, A. Vannucchi, A.M. Vannucchi, ALESSANDRO M. VANNUCCHI, Alessandro M Vannucchi

1.2K

Publications

52.3K

Citations

109

H-Index

168

Concepts

All Affiliations

University of Florence Azienda Ospedaliero-Universitaria Careggi Istituti di Ricovero e Cura a Carattere Scientifico Guy's and St Thomas' NHS Foundation Trust Ospedale Papa Giovanni XXIII

About

Alessandro M. Vannucchi is an author at University of Florence specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	44	100	7.5K
2	Health Sciences	20	29	2K
3	Public Health	9	9	940
4	Engineering	4	4	71
5	Natural Sciences	1	1	14

Alessandro M. Vannucchi

379

Publications

41.6K

Citations

100

H-Index

Page 1

	Year	Citations
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, Blood	2022	2.4K
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis Claire Harrison, Jean‐Jacques Kiladjian, Haifa Kathrin Al‐Ali, New England Journal of Medicine	2012	1.8K
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i> Jyoti Nangalia, Charles Massie, E. Joanna Baxter, New England Journal of Medicine	2013	1.7K
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment Francisco Cervantes, Brigitte Dupriez, Arturo Pereira, Blood	2008	1.2K
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment) Francesco Passamonti, Francisco Cervantes, Alessandro M. Vannucchi, Blood	2009	954
Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel Ayalew Tefferi, Jüergen Thiele, Attilio Orazi, Blood	2007	857
Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, Martin Grießhammer, New England Journal of Medicine	2015	851
Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet Tiziano Barbui, Giovanni Barosi, Gunnar Birgegård, Journal of Clinical Oncology Mixed-phenotype Acute LeukemiaEuropean LeukemianetPathologyTumor BiologyMyeloid Neoplasia	2011	825
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis Ayalew Tefferi, Paola Guglielmelli, Dirk R. Larson, Blood	2014	712
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study Ayalew Tefferi, Elisa Rumi, Guido Finazzi, Leukemia	2013	653

Page 1